IM botulinum toxin-A improves ambulation in severe haemophilia and cerebral palsy

1. Carr LJ, Cosgrove AP, Gringas P, Neville BGR, on behalf of the UK Botulinum Toxin and cerebral palsy working party. Position paper on the use of botulinum toxin in cerebral palsy. Arch Dis Child 1998; 79: 271O27310.1136/adc.79.3.271Search in Google Scholar

2. Delgado MR, Hirtz D, Aisen M, et al. Practice Parameter: Pharmocologic treatment of spasticity in children and adolescents with cerebral palsy Pan evidenceObased reviewQ Report of the quality standards subcommittee of the child neurology society. Neurology 2010; 74: 336O343.10.1212/WNL.0b013e3181cbcd2fOpen DOISearch in Google Scholar

3. Love SC, Novak I, Kentish M, et al. Botulinum toxin assessment, intervention and after care for lower limb spasticity in children with cerebral palsy:international consensus statement. European J Neurol 2010, 17 PSupplQ 9O37.10.1111/j.1468-1331.2010.03126.xOpen DOISearch in Google Scholar

4. Corry IS, Cosgrove AP, Duffy CM, et al. Botulinum toxin A compared with stretching casts in the treatment of spastic equines: a randomized prospective trial. J Ped Orthopaedics 1998, 18, 304O311.10.1097/01241398-199805000-00006Search in Google Scholar

5. Cosgrove AP, Corry IS, Graham HK. Botulinum toxin in the management of the lower limb in cerebral palsy. Dev Med Child Neurol 1994; 36: 386O396.10.1111/j.1469-8749.1994.tb11864.xSearch in Google Scholar

6. Graham HK, Aokia KR, AuttiORamob, et al. Recommendations for the use of botulinum toxin type A in the management of cerebral palsy. Gait Posture 2000; 11: 67O79.10.1016/S0966-6362(99)00054-5Open DOISearch in Google Scholar

7. Ward A. LongOterm modifications of spasticity. J Rehabil Med 2003; 35: 60O65.Search in Google Scholar

8. de Paiva A, Muenier FA, Molgo J, et al. Functional repair of motor endplates after botulinum neurotixin type A poisoning:biphasic switch of synaptic activity between nerve sprouts and their parent terminals. Proc Natl Acad Sci USA 1999; 96: 3220O5.10.1073/pnas.96.6.32001591910077661Search in Google Scholar

9. Boyd RN, Graham HK. Objective measurement of clinical findings in the use of botulinum toxin type A for the management of children with cerebral palsy. European J Neurol 1999; 6 PSupplQ: 23O35.10.1111/j.1468-1331.1999.tb00031.xOpen DOISearch in Google Scholar

10. Ashworth B. Preliminary trial of carisoprodal in multiple sclerosis. Practitioner 1964; 192: 540O542.Search in Google Scholar

11. Palisanao R, Rosenbaum P, Walter S, et al. Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol 1997; 39: 214O233.10.1111/j.1469-8749.1997.tb07414.x9183258Search in Google Scholar